Colby Stong

In patients with COPD, are the outcomes of triple therapy with FF/UMEC/VI vs dual therapy with FF/VI and UMEC/VI affected by the patient’s smoking status?

A systematic review of the published literature is conducted to collect data regarding chronic dermatoses exacerbation after COVID-19 vaccination.

A large, retrospective claims data study identified patients with PH and COPD and analyzed how many of these patients used medications for each of these conditions.

Do patients with COVID-19-related ARDS have distinct respiratory system static compliance phenotypes and thus require an individualized approach to ventilation?

A COPD self-management program adapted for use as a group intervention was assessed for its feasibility and acceptability to patients and providers.

A meta-analysis assessed exercise capacity, as measured by CPET, more than 3 months after COVID-19 infection in those with and without long COVID symptoms.

Investigators assessed the relationship between COVID-19 illness severity and post-COVID dyspnea, exercise capacity, spirometry, and gas exchange.

The ACT trial assessed the value of colchicine and combined rivaroxaban/aspirin therapies for preventing of COVID-19 progression in hospitalized patients.

Researchers assessed the readmission and death rates at 6 months for individuals undergoing percutaneous cholecystostomy.

A systematic review examined factors associated with mortality in patients receiving venovenous ECMO for COVID-19-related respiratory failure.

A study was conducted to examine the relationship between intimate partner violence in young adulthood and cardiovascular events in middle age.

Researchers evaluated the potential relationship between a genetic predisposition to psoriasis and COVID-19 infection.

In those who were hospitalized for COVID-19, how does cardiopulmonary exercise capacity change during the 12 months following hospital discharge?

Researchers examined the association between COVID-19 and enteric and autonomic dysfunction in a large cohort of 80 million people.

To what extent do patients with COPD aged 40 to 65 years follow GOLD 2020 recommendations for receiving influenza and pneumococcus vaccinations?

Researchers evaluated the efficacy and safety of fecal microbiota transplantation after vancomycin vs vancomycin alone for first or second C difficile infection.

How does use of a helmet vs facemask for CPAP affect rates of survival and intubation in patients with acute hypoxemic respiratory failure due to COVID-19?

Demographics, clinical variables, and outcomes associated with psoriasis following COVID-19 vaccination are reviewed.

How can persistent hyposnia from COVID-19 be distinguished from olfactory impairment exhibited by those with mild cognitive impairment?

Researchers assessed the clinical benefit of tracheostomy, which is often indicated for patients needing prolonged intubation, for patients with severe COVID-19.

A study was conducted to determine and compare biological, clinical, and radiologic features in patients with aortitis.

Can a year-long home strength training program help patients with COPD to maintain gains made through pulmonary rehabilitation?

A study was conducted to determine the effect of history of cardiovascular conditions on severity of COVID-19 infection in pediatric patients.

Could the level of plasma immunoglobulin E in patients with COPD serve as a potential biomarker for predicting future exacerbation risk and mortality?

Researchers estimated the global, regional, and national prevalence of hepatitis B virus in addition to mortality and disability-adjusted life-years from 1990 to 2019.

Does the Covichem score accurately estimate COVID-19 severity and mortality risk upon hospital admission? An external validation study examined this question.

Could thoracic HRCT semiquantitative scoring offer a rapid and accurate method for identifying patients with severe COVID-19 who are at risk for poor outcomes?

Investigators sought to develop and validate the COVID-HEART predictor to determine risk for adverse events in patients hospitalized with COVID-19.

Researchers examined the effects of N sativa oil supplementation on cardiometabolic measures in patients with NAFLD.

Researchers estimated the global disease burden of respiratory syncytial virus among children and infants.